.png){kind=icon}
.png){kind=icon}
Return
Cardiovascular Outcomes of GLP-1–Based Medicines Among People With Overweight and Obesity: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials
.png){kind=icon}
OA
AI
M
E
S
T
A
J
N
DOI：10.1111/obr.70198.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Cardiovascular (CV) outcomes of Glucagon-like peptide-1 (GLP-1)–based medicines among people with overweight and obese (OW/OB) population have been investigated by meta-analyses of randomized controlled trials (RCTs), but an overall summary is lacking.
Keywords:
cardiovascular
GLP-1 RA
meta-analysis
obesity
overweight
umbrella review
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.4
Papers:
2.8K
Citations:
1.8W
Organization
Cited Papers